Humanwell Healthcare insists on R&D as the guide
Humanwell Healthcare insists on R&D as the guide, and is at the forefront of R&D investment and new drug R&D progress among domestic pharmaceutical enterprises, and is committed to building a first-class platform for R&D and industrialization of new drugs in China.
EqualOcean Sector Quarterly Report - Healthcare Sectors
To help worldwide investors keep track of what is happening in each industry or sector and the related hot spots, we launched the EqualOcean Sector Quarterly Report series, which gathers notable information and statistics in each quarter.
Apr 07, 2022 01:44 PM
ResearchTechnology, Healthcare, Consumer Staples
WIA2020 | Rising Tech Stars 2020: Global & China's 100
ResearchTechnology, Consumer Staples, Real Estate
Tech for Global, Globalization Footprints of the Established and the New
R&D of Anti-COVID-19 Drugs is Blooming in China
Anti-epidemic stocks moved higher in early trading of the Hong Kong Stock Exchange today, with Kintor Pharma-B (Chinese: 开拓药业,09939:HK) and Shandong Xinhua Pharmaceutical (Chinese: 新华制药,00719:HK) leading the rally on the back of thriving R&D of anti-coronavirus drugs.
Updated 1 hour ago